Ensuring timely antibody supply during the COVID-19 pandemic - contact us for solutions

Goat Anti-Guinea Pig IgG(H+L)-FITC

Cat. No.:
Goat Anti-Guinea Pig IgG(H+L)-FITC antibody for use in immunohistochemistry / immunocytochemistry and western blot assays.
Size Price (USD) Quantity
1.0 mg $50.00
More Information
Isotype Goat IgG
Isotype Control Goat IgG-FITC
Specificity Reacts with the heavy and light chains of guinea pig IgG
Source Pooled antisera from goats hyperimmunized with guinea pig IgG
Cross Adsorption None; may react with immunoglobulins from other species and the light chains of other guinea pig immunoglobulins
Purification Method Affinity chromatography on guinea pig IgG covalently linked to agarose
Conjugate FITC (Fluorescein)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide
Clonality Polyclonal
Concentration 1.0 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light
Applications Quality tested applications for relevant formats include -

Other referenced applications for relevant formats include -
Immunohistochemistry-Frozen Sections 10,11
Immunohistochemistry-Paraffin Sections 12-14
Immunocytochemistry 15,16
Western Blot 17-21
RRID Number AB_2796155

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view

Need help with this product?
or call 800.722.2255
  1. 1. Coëffier E, Excler J, Kieny MP, Meignier B, Moste C, Tartaglia J, et al. Restricted specificity of anti-V3 antibodies induced in humans by HIV candidate vaccines. AIDS Res Hum Retroviruses. 1997;13:1471-85. (ELISA)
  2. 2. McCracken AA, Werner ED, Powell MJ, Kruse KB, Brodsky JL. Differential fates of invertase mutants in the yeast endoplasmic reticulum. Yeast. 2000;16:49-55. (ELISA)
  3. 3. Pilorz V, Jäckel M, Knudsen K, Trillmich F. The cost of a specific immune response in young guinea pigs. Physiol Behav. 2005;85:205-11. (ELISA)
  4. 4. Ryder AB, Tollefson SJ, Podsiad AB, Johnson JE, Williams JV. Soluble recombinant human metapneumovirus G protein is immunogenic but not protective. Vaccine. 2010;28:4145-52. (ELISA, WB)
  5. 5. de Jonge MI, Keizer SA, el Moussaoui HM, van Dorsten L, Azzawi R, van Zuilekom HI, et al. A novel guinea pig model of Chlamydia trachomatis genital tract infection. Vaccine. 2011;29:5594-6001. (ELISA)
  6. 6. Velasquez LS, Shira S, Berta AN, Kilbourne J, Medi BM, Tizard I, et al. Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine. Vaccine. 2011;29:5221-31. (ELISA)
  7. 7. Schiött Å, Larsson K, Manniche S, Kalliomäki S, Heydenreich AV, Dalsgaard K, et al. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses. Int J Pharm. 2011;414:312-20. (ELISA)
  8. 8. Baldwin SL, Bertholet S, Reese VA, Ching LK, Reed SG, Coler RN. The importance of adjuvant formulation in the development of a tuberculosis vaccine. J Immunol. 2012;188:2189-97. (ELISA)
  9. 9. Rebollar PG, Dal Bosco A, Millán P, Cardinali R, Brecchia G, Sylla L, et al. Ovulating induction methods in rabbit does: the pituitary and ovarian responses. Theriogenology. 2012;77:292-8. (ELISA)
  10. 10. Yamada K, Fukaya M, Shibata T, Kurihara H, Tanaka K, Inoue Y, et al. Dynamic transformation of Bergmann glial fibers proceeds in correlation with dendritic outgrowth and synapse formation of cerebellar Purkinje cells. J Comp Neurol. 2000;418:106-20. (IHC-FS)
  11. 11. Kraus LM, Gaber L, Handorf CR, Marti H, Kraus AP. Carbamoylation of glomerular and tubular proteins in patients with kidney failure: a potential mechanism of ongoing renal damage. Swiss Med Wkly. 2001;131:139-45. (IHC-FS)
  12. 12. Fukaya M, Yamada K, Nagashima M, Tanaka K, Watanabe M. Down-regulated expression of glutamate transporter GLAST in Purkinje cell-associated astrocytes of reeler and weaver mutant cerebella. Neurosci Res. 1999;34:165-75. (IHC-PS)
  13. 13. Klymiuk N, van Buerck L, Bähr A, Offers M, Kessler B, Wuensch A, et al. Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice. Diabetes. 2012;61:1527-32. (IHC-PS)
  14. 14. Streckel E, Braun-Reichhart C, Herbach N, Dahlhoff M, Kessler B, Blutke A. Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic condition. J Transl Med. 2015;13:73. (IHC-PS)
  15. 15. Yao Q, Compans RW. Filamentous particle formation by human parainfluenza virus type 2. J Gen Virol. 2000;81:1305-12. (ICC)
  16. 16. Cseke G, Maginnis MS, Cox RG, Tollefson SJ, Podsiad AB, Wright DW, et al. Integrin αvβ1 promotes infection by human metapneumovirus. Proc Natl Acad Sci USA. 2009;106:1566-71. (ICC)
  17. 17. Vasilakos JP, Michael JG. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells. J Immunol. 1993;150:2346-55. (WB)
  18. 18. King MC, Raposo G, Lemmon MA. Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB. Proc Natl Acad Sci USA. 2004;101:8957-62. (WB)
  19. 19. Dalen KT, Ulven SM, Arntsen BM, Solaas K, Nebb HI. PPARα activators and fasting induce the expression of adipose differentiation-related protein in liver. J Lipid Res. 2006;47:931-43. (WB)
  20. 20. Cseke G, Wright DW, Tollefson SJ, Johnson JE, Crowe JE Jr, Williams JV. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J Virol. 2007;81:698-707. (WB)
  21. 21. Nobre RJ, Herráez-Hernández E, Fei J, Langbein L, Kaden S, Gröne H, et al. E7 oncoprotein of novel human papillomavirus type 108 lacking the E6 gene induces dysplasia in organotypic keratinocyte cultures. J Virol. 2009;83:2907-16. (WB)
See All References